Artem Vladimirovich Marukhov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Artem Vladimirovich Marukhov has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Mikhail V. Zakharov
Kirov Military Medical Academy
11 shared publications - Natal'YA Valer'EVna Chubchenko
Military Medical Academy named after S.M. Kirov
8 shared publications - Marat Adessovich Magomedov
Pirogov Russian National Research Medical University (RNRMU), Moscow, Russia; N.I. Pirogov City Clinical Hospital No 1, Moscow, Russia
6 shared publications - Denis Nikolaevich Protsenko
Pirogov Russian National Research Medical University
5 shared publications - Sergey Viktorovich Masolitin
Pirogov City Clinical Hospital № 1, Moscow, Russia
5 shared publications - Andrey O. Bykov
Pirogov Russian National Research Medical University
3 shared publications
Latest Publications
- Open Access
- 29 December 2025
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Messenger of ANESTHESIOLOGY AND RESUSCITATION
- Vol. 22 (6) , 67-79
Evaluation of the efficacy of extracorporeal blood purification in abdominal septic shock: a prospective interventional controlled study
Introduction. The choice of extracorporeal blood purification (EBP) tactics for septic shock (SS) complicated by acute kidney injury (AKI) remains an unresolved clinical problem. The objective was to evaluate the effectiveness of various EBP approaches in SS management. Materials and methods. Three groups were included in the study: group 1 (n = 34) received conservative therapy and hemodiafiltration (CVVHDF) for urgent indications; group 2 (n = 35) received early isolated CVVHDF; group 3 (n = 32) received early combined EBP (selective plasmapheresis with CVVHDF). We conducted a comparative analysis of clinical and laboratory parameters. Results. Application of early combined EBP as part of intensive therapy by day 3 provided a significantly better stabilization of mean arterial pressure – in 37.7% of cases (p = 0.001) – compared to isolated EBP in the early (18.3%, p = 0.042) and delayed periods (12.8%, p = 0.016); reduced organ dysfunction severity (p = 0.002) compared to day 5 outcomes with early isolated EBP (p = 0.021). ICU and hospital stays were 10.5 (6.7; 15) and 21 (18; 25) days respectively, versus 15 (9.5; 20) and 24 (17.5; 27.5) days for early isolated EBP (p = 0.054 and p = 0.267), and 21 (13.2; 26) and 27.5 (22; 41) days for delayed EBP (p = 0.001 for both). Mortality was 28.1% in the combined group versus 42.9% for early isolated EBP (p = 0.112) and 58.7% for delayed EBP (p = 0.012). Conclusions. Combined EBP as part of intensive therapy enables faster hemodynamic stabilization, improves patients’ clinical status, and leads to better disease outcomes.
- 29 December 2025
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Messenger of ANESTHESIOLOGY AND RESUSCITATION
- Vol. 22 (6) , 67-79
Open AccessEvaluation of the efficacy of extracorporeal blood purification in abdominal septic shock: a prospective interventional controlled study
Introduction. The choice of extracorporeal blood purification (EBP) tactics for septic shock (SS) complicated by acute kidney injury (AKI) remains an unresolved clinical problem. The objective was to evaluate the effectiveness of various EBP approaches in SS management. Materials and methods. Three groups were included in the study: group 1 (n = 34) received conservative therapy and hemodiafiltration (CVVHDF) for urgent indications; group 2 (n = 35) received early isolated CVVHDF; group 3 (n = 32) received early combined EBP (selective plasmapheresis with CVVHDF). We conducted a comparative analysis of clinical and laboratory parameters. Results. Application of early combined EBP as part of intensive therapy by day 3 provided a significantly better stabilization of mean arterial pressure – in 37.7% of cases (p = 0.001) – compared to isolated EBP in the early (18.3%, p = 0.042) and delayed periods (12.8%, p = 0.016); reduced organ dysfunction severity (p = 0.002) compared to day 5 outcomes with early isolated EBP (p = 0.021). ICU and hospital stays were 10.5 (6.7; 15) and 21 (18; 25) days respectively, versus 15 (9.5; 20) and 24 (17.5; 27.5) days for early isolated EBP (p = 0.054 and p = 0.267), and 21 (13.2; 26) and 27.5 (22; 41) days for delayed EBP (p = 0.001 for both). Mortality was 28.1% in the combined group versus 42.9% for early isolated EBP (p = 0.112) and 58.7% for delayed EBP (p = 0.012). Conclusions. Combined EBP as part of intensive therapy enables faster hemodynamic stabilization, improves patients’ clinical status, and leads to better disease outcomes.
- Open Access
- 11 August 2025
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Messenger of ANESTHESIOLOGY AND RESUSCITATION
- Vol. 22 (4) , 17-30
The role of extracorporeal blood purification in correcting intoxication markers in septic shock: a prospective interventional controlled study
Introduction. The use of extracorporeal blood purification (EBP) in septic shock (SS) complicated by acute kidney injury (AKI) remains a con troversial topic.The objective was to evaluate the effectiveness of EBP methods in patients with abdominal SS complicated by AKI.Materials and methods. Group 1 included 34 patients who received continuous veno-venous hemodiafiltration (CVVHDF) as emergency therapy. Group 2 consisted of 35 patients who underwent early isolated CVVHDF. Group 3 comprised 32 patients who received early combined EBP (selec tive plasma filtration + CVVHDF).Results. Combined EBP from day 1 to day 5 of therapy demonstrated a reduction in C-reactive protein from 223.5 to 140.9 mg/L (p = 0.001; −37.1%) compared to group 2 (219.7 to 179.2 mg/L; p = 0.004; −18.4%) and group 1 (214.5 to 189.3 mg/L; p = 0.772; −11.7%), as well as a decrease in interleukin-6 from 242.8 to 70.3 pg/mL (p = 0.001; −71.1%) vs. group 2 (233.7 to 123.4 pg/mL; p = 0.003; −47.2%) and group 1 (247.4 to 184.3 pg/mL; p = 0.512; −25.5%). Tumor necrosis factor levels decreased from 20.1 to 4.6 pg/mL (p = 0.001; −77.1%) in group 3, while group 2 showed a reduction from 19.4 to 11.9 pg/mL (p = 0.001; −38.7%) and group 1 exhibited minimal change (21.4 to 20.5 pg/mL; p = 0.525; −4.2%). Cystatin-C levels in group 3 decreased from 1.45 to 0.85 µg/mL (p = 0.048; −41.4%), whereas group 2 showed a slight reduction (1.6 to 1.5 µg/mL; p = 0.997; −6.3%) and group 1 demonstrated an increase (1.5 to 1.9 µg/mL; p = 0.027; +22.7%).Conclusions. Combined EBP significantly reduces inflammatory markers and improves kidney function compared to isolated renal replacement therapy, both in the early and delayed periods.
- 11 August 2025
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Messenger of ANESTHESIOLOGY AND RESUSCITATION
- Vol. 22 (4) , 17-30
Open AccessThe role of extracorporeal blood purification in correcting intoxication markers in septic shock: a prospective interventional controlled study
Introduction. The use of extracorporeal blood purification (EBP) in septic shock (SS) complicated by acute kidney injury (AKI) remains a con troversial topic.The objective was to evaluate the effectiveness of EBP methods in patients with abdominal SS complicated by AKI.Materials and methods. Group 1 included 34 patients who received continuous veno-venous hemodiafiltration (CVVHDF) as emergency therapy. Group 2 consisted of 35 patients who underwent early isolated CVVHDF. Group 3 comprised 32 patients who received early combined EBP (selec tive plasma filtration + CVVHDF).Results. Combined EBP from day 1 to day 5 of therapy demonstrated a reduction in C-reactive protein from 223.5 to 140.9 mg/L (p = 0.001; −37.1%) compared to group 2 (219.7 to 179.2 mg/L; p = 0.004; −18.4%) and group 1 (214.5 to 189.3 mg/L; p = 0.772; −11.7%), as well as a decrease in interleukin-6 from 242.8 to 70.3 pg/mL (p = 0.001; −71.1%) vs. group 2 (233.7 to 123.4 pg/mL; p = 0.003; −47.2%) and group 1 (247.4 to 184.3 pg/mL; p = 0.512; −25.5%). Tumor necrosis factor levels decreased from 20.1 to 4.6 pg/mL (p = 0.001; −77.1%) in group 3, while group 2 showed a reduction from 19.4 to 11.9 pg/mL (p = 0.001; −38.7%) and group 1 exhibited minimal change (21.4 to 20.5 pg/mL; p = 0.525; −4.2%). Cystatin-C levels in group 3 decreased from 1.45 to 0.85 µg/mL (p = 0.048; −41.4%), whereas group 2 showed a slight reduction (1.6 to 1.5 µg/mL; p = 0.997; −6.3%) and group 1 demonstrated an increase (1.5 to 1.9 µg/mL; p = 0.027; +22.7%).Conclusions. Combined EBP significantly reduces inflammatory markers and improves kidney function compared to isolated renal replacement therapy, both in the early and delayed periods.
- 11 June 2025
- Published by Media Sphere Publishing Group in Russian Journal of Anesthesiology and Reanimatology
- No. 3
The first experience of using a device for selective hemosorption of lipopolysaccharide “Toxipak 300” in the treatment of patients with septic shock
Objective. To evaluate the clinical and laboratory efficacy, safety and ease of use of the device for LPS adsorption “Toxipak 300” in the treatment of patients with septic shock. Material and methods. The study included 5 patients with septic shock and a high level of endotoxin activity (EAA >0.6) in the blood who were treated at the clinics of the Military Medical Academy. All patients included in the study underwent from 1 to 2 operations of LPS adsorption. The effectiveness of LPS adsorption operations was evaluated by studying the dynamics of blood pressure, the dose of vasopressor support, the vasopressor dependence index (VDI), the severity of organ dysfunction on the SOFA, the level of EAA in the blood, the functional state of neutrophils, laboratory indicators of systemic inflammation, endogenous intoxication, tissue perfusion. Results. A day after LPS adsorption, there was a statistically significant decrease in the dose of vasopressor support with norepinephrine (p=0.026) and VDI (p=0.028). In three of the seven cases of LPS adsorption, septic shock was stopped during the following days. In three other cases, there was a significant decrease in the required dose of norepinephrine and VDI. In one case, an increase in these indicators was noted. There were no significant changes in the values of laboratory parameters reflecting the severity of endotoxinemia, systemic inflammatory response and tissue perfusion disorders. When studying the safety of using the “Toxipak 300” LPS adsorption device, it was found that no severe complications and clinically significant adverse events were detected during its operation. Conclusion. LPS adsorption using the “Toxipak 300” device is safe enough, it is not accompanied by the development of severe complications and clinically significant adverse events. The presence, in most cases, of positive changes in the clinical parameters of central hemodynamics in patients with septic shock against the background of the absence of significant improvements in laboratory parameters of endotoxinemia, systemic inflammatory response and tissue perfusion disorders, along with a small number of patients included in the study, require additional clinical and experimental studies aimed at determining the effectiveness of this device.
- 11 June 2025
- Published by Media Sphere Publishing Group in Russian Journal of Anesthesiology and Reanimatology
- No. 3
The first experience of using a device for selective hemosorption of lipopolysaccharide “Toxipak 300” in the treatment of patients with septic shock
Objective. To evaluate the clinical and laboratory efficacy, safety and ease of use of the device for LPS adsorption “Toxipak 300” in the treatment of patients with septic shock. Material and methods. The study included 5 patients with septic shock and a high level of endotoxin activity (EAA >0.6) in the blood who were treated at the clinics of the Military Medical Academy. All patients included in the study underwent from 1 to 2 operations of LPS adsorption. The effectiveness of LPS adsorption operations was evaluated by studying the dynamics of blood pressure, the dose of vasopressor support, the vasopressor dependence index (VDI), the severity of organ dysfunction on the SOFA, the level of EAA in the blood, the functional state of neutrophils, laboratory indicators of systemic inflammation, endogenous intoxication, tissue perfusion. Results. A day after LPS adsorption, there was a statistically significant decrease in the dose of vasopressor support with norepinephrine (p=0.026) and VDI (p=0.028). In three of the seven cases of LPS adsorption, septic shock was stopped during the following days. In three other cases, there was a significant decrease in the required dose of norepinephrine and VDI. In one case, an increase in these indicators was noted. There were no significant changes in the values of laboratory parameters reflecting the severity of endotoxinemia, systemic inflammatory response and tissue perfusion disorders. When studying the safety of using the “Toxipak 300” LPS adsorption device, it was found that no severe complications and clinically significant adverse events were detected during its operation. Conclusion. LPS adsorption using the “Toxipak 300” device is safe enough, it is not accompanied by the development of severe complications and clinically significant adverse events. The presence, in most cases, of positive changes in the clinical parameters of central hemodynamics in patients with septic shock against the background of the absence of significant improvements in laboratory parameters of endotoxinemia, systemic inflammatory response and tissue perfusion disorders, along with a small number of patients included in the study, require additional clinical and experimental studies aimed at determining the effectiveness of this device.
- Open Access
- 25 May 2025
- Published by ECO-Vector LLC in Russian Military Medical Academy Reports
- Vol. 44 (1) , 49-59
Features of Acute Kidney Injury in Combat Casualties During Modern Armed Conflict
Background: In modern armed conflicts, wounds and injuries of various etiologies have become an inherent component of combat operations. The main research directions concerning such injuries are aimed at identifying causal relationships between the nature of the trauma, the features of its acute phase, and the development of complications, including acute kidney injury. A review of the literature revealed sufficient information on the leading pathophysiological mechanisms underlying the development of acute kidney injury. However, early diagnostic methods for this complication have not yet been developed, which prompted the conduct of this study. AIM: To identify factors influencing the risk of acute kidney injury in combat casualties and to determine the frequency of the leading pathogenetic mechanisms in the early phase of traumatic disease. MATERIALS AND METHODS: A prospective analysis was conducted involving 104 patients with wounds who were admitted to the 1602 Military Clinical Hospital of the Ministry of Defense of the Russian Federation (Rostov-on-Don) between January and March 2024. Upon admission to the multidisciplinary hospital, the severity of patients’ conditions was assessed using the admission condition scale developed by the Department of military field surgery. Based on the assessment results, patients were divided into three categories: 1—patients with decompensated traumatic disease (score 34; 17 patients, 16.4%); 2—patients with subcompensated traumatic disease (score 25–34; 49 patients, 47.1%); 3—patients with compensated traumatic disease (score ≤24; 38 patients, 36.5% of the total). Assessment included medical history, evaluation of vital signs, 24-hour urine output measurement, complete blood count, urinalysis, serial blood chemical analysis (three measurements), electrocardiography, and chest X-ray. Statistical processing of the experimental data was performed using SPSS Statistics 27 (IBM). RESULTS: As a result of the study, diagnostic factors influencing the risk of this complication in the early phase of traumatic disease were identified, including hemoglobin, hematocrit, creatinine, estimated glomerular filtration rate, urea, 24-hour urine output, and potassium levels; their statistical significance was confirmed. Based on the intergroup analysis of the obtained data, no cases of acute kidney injury were recorded in the group of patients with compensated traumatic disease. The incidence of acute kidney injury was 82.3% among patients with decompensated traumatic disease and 24.5% among those with subcompensated disease. Of the 26 patients diagnosed with acute kidney injury, 12 (46.1%) presented with a non-oliguric form. The leading pathogenetic mechanisms were prerenal acute kidney injury due to hypovolemia (69.2%), renal injury associated with rhabdomyolysis (23%), and metabolic acidosis (8.3%). CONCLUSION: The results obtained in this study indicate a high incidence of acute kidney injury (up to 25%) among patients with wounds and injuries in modern armed conflict, with prerenal mechanisms being the predominant pathogenetic variant. Due to the limited diagnostic value of standard methods, particularly in patients presenting with the non-oliguric form, it is essential to develop a comprehensive approach to the diagnosis of acute kidney injury in wounded and injured individuals. This approach should incorporate modern laboratory biomarkers and be applied during the early phase of traumatic disease.
- 25 May 2025
- Published by ECO-Vector LLC in Russian Military Medical Academy Reports
- Vol. 44 (1) , 49-59
Open AccessFeatures of Acute Kidney Injury in Combat Casualties During Modern Armed Conflict
Background: In modern armed conflicts, wounds and injuries of various etiologies have become an inherent component of combat operations. The main research directions concerning such injuries are aimed at identifying causal relationships between the nature of the trauma, the features of its acute phase, and the development of complications, including acute kidney injury. A review of the literature revealed sufficient information on the leading pathophysiological mechanisms underlying the development of acute kidney injury. However, early diagnostic methods for this complication have not yet been developed, which prompted the conduct of this study. AIM: To identify factors influencing the risk of acute kidney injury in combat casualties and to determine the frequency of the leading pathogenetic mechanisms in the early phase of traumatic disease. MATERIALS AND METHODS: A prospective analysis was conducted involving 104 patients with wounds who were admitted to the 1602 Military Clinical Hospital of the Ministry of Defense of the Russian Federation (Rostov-on-Don) between January and March 2024. Upon admission to the multidisciplinary hospital, the severity of patients’ conditions was assessed using the admission condition scale developed by the Department of military field surgery. Based on the assessment results, patients were divided into three categories: 1—patients with decompensated traumatic disease (score 34; 17 patients, 16.4%); 2—patients with subcompensated traumatic disease (score 25–34; 49 patients, 47.1%); 3—patients with compensated traumatic disease (score ≤24; 38 patients, 36.5% of the total). Assessment included medical history, evaluation of vital signs, 24-hour urine output measurement, complete blood count, urinalysis, serial blood chemical analysis (three measurements), electrocardiography, and chest X-ray. Statistical processing of the experimental data was performed using SPSS Statistics 27 (IBM). RESULTS: As a result of the study, diagnostic factors influencing the risk of this complication in the early phase of traumatic disease were identified, including hemoglobin, hematocrit, creatinine, estimated glomerular filtration rate, urea, 24-hour urine output, and potassium levels; their statistical significance was confirmed. Based on the intergroup analysis of the obtained data, no cases of acute kidney injury were recorded in the group of patients with compensated traumatic disease. The incidence of acute kidney injury was 82.3% among patients with decompensated traumatic disease and 24.5% among those with subcompensated disease. Of the 26 patients diagnosed with acute kidney injury, 12 (46.1%) presented with a non-oliguric form. The leading pathogenetic mechanisms were prerenal acute kidney injury due to hypovolemia (69.2%), renal injury associated with rhabdomyolysis (23%), and metabolic acidosis (8.3%). CONCLUSION: The results obtained in this study indicate a high incidence of acute kidney injury (up to 25%) among patients with wounds and injuries in modern armed conflict, with prerenal mechanisms being the predominant pathogenetic variant. Due to the limited diagnostic value of standard methods, particularly in patients presenting with the non-oliguric form, it is essential to develop a comprehensive approach to the diagnosis of acute kidney injury in wounded and injured individuals. This approach should incorporate modern laboratory biomarkers and be applied during the early phase of traumatic disease.
- Open Access
- 1 May 2025
- Published by ECO-Vector LLC in Bulletin of the Russian Military Medical Academy
- Vol. 27 (1) , 93-104
Modern early diagnostic methods for acute kidney injury in wounded and injured patients
Background: This study substantiated the development of a mathematical model for predicting acute kidney injury (AKI) at the stage of qualified medical care and a diagnostic method for early detection of this complication in trauma-related disease using immunochromatographic test strips for cystatin C detection in single urine samples. Materials and methods: The study involved two phases. In phase 1, upon hospital admission, the patients’ condition was assessed using a military field surgery scale for severity evaluation. A complete blood count and urinalysis were performed, as well as three sequential biochemical blood tests to determine standard AKI markers. Obtained data were used to develop a predictive formula for AKI. In phase 2, retrospectively, after preliminary sample preparation, an AKI diagnostic method was employed using the developed immunochromatographic test strips for cystatin C detection in a single urine sample. Results: Upon applying a urine sample to the test strip, it interacts with a conjugate, and a control marker appears. If cystatin C binds to specific antibodies, two lines appear, indicating a positive test result. The method allows for the verification of AKI with 80% accuracy in the early phase of trauma-related disease. Conclusions: This study highlights the importance of a comprehensive approach that incorporates a predictive model on hospital admission of wounded patients. Implementing rapid diagnostic methods using cystatin C in the early stages of medical care improves triage efficiency, facilitates intensive therapy, and optimizes patient management during evacuation delays.
- 1 May 2025
- Published by ECO-Vector LLC in Bulletin of the Russian Military Medical Academy
- Vol. 27 (1) , 93-104
Open AccessModern early diagnostic methods for acute kidney injury in wounded and injured patients
Background: This study substantiated the development of a mathematical model for predicting acute kidney injury (AKI) at the stage of qualified medical care and a diagnostic method for early detection of this complication in trauma-related disease using immunochromatographic test strips for cystatin C detection in single urine samples. Materials and methods: The study involved two phases. In phase 1, upon hospital admission, the patients’ condition was assessed using a military field surgery scale for severity evaluation. A complete blood count and urinalysis were performed, as well as three sequential biochemical blood tests to determine standard AKI markers. Obtained data were used to develop a predictive formula for AKI. In phase 2, retrospectively, after preliminary sample preparation, an AKI diagnostic method was employed using the developed immunochromatographic test strips for cystatin C detection in a single urine sample. Results: Upon applying a urine sample to the test strip, it interacts with a conjugate, and a control marker appears. If cystatin C binds to specific antibodies, two lines appear, indicating a positive test result. The method allows for the verification of AKI with 80% accuracy in the early phase of trauma-related disease. Conclusions: This study highlights the importance of a comprehensive approach that incorporates a predictive model on hospital admission of wounded patients. Implementing rapid diagnostic methods using cystatin C in the early stages of medical care improves triage efficiency, facilitates intensive therapy, and optimizes patient management during evacuation delays.
- Open Access
- 30 April 2025
- Published by Practical Medicine Publishing House in Annals of Critical Care
- No. 2,p. 58-73
Selective plasmofiltration in the treatment of patients with abdominal septic shock: a prospective interventional controlled study
INTRODUCTION: The choice of tactics for the use of extracorporeal detoxification in the form of indications and modality of procedures in patients with abdominal septic shock (SS) remains an unsolved problem. OBJECTIVES: To evaluate the effect of selective plasmofiltration (SPF) as part of complex intensive therapy on the dynamics of markers of systemic inflammatory response syndrome, the severity of the condition and disease outcomes in patients with abdominal SS. MATERIALS AND METHODS: The study included 85 patients with the clinical picture of abdominal SS complicated by acute kidney injury. Group 1 (23 patients) received combined detoxification: SPF and continuous renal replacement therapy (CVVHDF). Group 2 (62 patients) received isolated CVVHDF. A comparative analysis of the main clinical and laboratory parameters and treatment outcomes was performed between the groups. RESULTS: The use of combined detoxification made it possible to reduce markers of systemic endogenous intoxication: C-reactive protein from 225.4 (211; 248.4) to 210.5 (180.39; 230.18) mg/l by the 3rd day of therapy (6.6 %; p = 0.0016), by the 5th–7th–10th days 156.17 (110.67; 180.62), 87 (74.5; 94.1), 62.2 (45.7; 71), respectively (30.7–61.4–72.4 %; p = 0.044; p = 0.0001; p = 0.0001); interleukin-6 demonstrated a decrease of 12.2 % by the 2nd day (p = 0.017) and 35.5, 39.4, 45.7 and 52.4 % by the 3rd–5th–7th–10th days of therapy, respectively (p = 0.022; p = 0.009; p = 0.0018; p = 0.0001); leukocytes from 19.7 (17.7; 22.4) to 17.25 × 109/l (14.65; 19.15) by the 3rd day (12.4 %; p = 0.00045), and 10.9 (9.3; 14.1) by the 10th day (44.7 %; p = 0.00048). Severity of organ dysfunction (SOFA) from 6 (4; 6) on the 1st day to 4 (3; 5) points by the 3rd day of therapy (p = 0.026). A significant difference in survival was obtained (p = 0.037). CONCLUSIONS: Combined detoxification consisting of SPF and CVVHDF allows for rapid normalization of laboratory markers of systemic inflammatory response syndrome and improves patient survival.
- 30 April 2025
- Published by Practical Medicine Publishing House in Annals of Critical Care
- No. 2,p. 58-73
Open AccessSelective plasmofiltration in the treatment of patients with abdominal septic shock: a prospective interventional controlled study
INTRODUCTION: The choice of tactics for the use of extracorporeal detoxification in the form of indications and modality of procedures in patients with abdominal septic shock (SS) remains an unsolved problem. OBJECTIVES: To evaluate the effect of selective plasmofiltration (SPF) as part of complex intensive therapy on the dynamics of markers of systemic inflammatory response syndrome, the severity of the condition and disease outcomes in patients with abdominal SS. MATERIALS AND METHODS: The study included 85 patients with the clinical picture of abdominal SS complicated by acute kidney injury. Group 1 (23 patients) received combined detoxification: SPF and continuous renal replacement therapy (CVVHDF). Group 2 (62 patients) received isolated CVVHDF. A comparative analysis of the main clinical and laboratory parameters and treatment outcomes was performed between the groups. RESULTS: The use of combined detoxification made it possible to reduce markers of systemic endogenous intoxication: C-reactive protein from 225.4 (211; 248.4) to 210.5 (180.39; 230.18) mg/l by the 3rd day of therapy (6.6 %; p = 0.0016), by the 5th–7th–10th days 156.17 (110.67; 180.62), 87 (74.5; 94.1), 62.2 (45.7; 71), respectively (30.7–61.4–72.4 %; p = 0.044; p = 0.0001; p = 0.0001); interleukin-6 demonstrated a decrease of 12.2 % by the 2nd day (p = 0.017) and 35.5, 39.4, 45.7 and 52.4 % by the 3rd–5th–7th–10th days of therapy, respectively (p = 0.022; p = 0.009; p = 0.0018; p = 0.0001); leukocytes from 19.7 (17.7; 22.4) to 17.25 × 109/l (14.65; 19.15) by the 3rd day (12.4 %; p = 0.00045), and 10.9 (9.3; 14.1) by the 10th day (44.7 %; p = 0.00048). Severity of organ dysfunction (SOFA) from 6 (4; 6) on the 1st day to 4 (3; 5) points by the 3rd day of therapy (p = 0.026). A significant difference in survival was obtained (p = 0.037). CONCLUSIONS: Combined detoxification consisting of SPF and CVVHDF allows for rapid normalization of laboratory markers of systemic inflammatory response syndrome and improves patient survival.
- 19 April 2024
- Published by Media Sphere Publishing Group in Russian Journal of Anesthesiology and Reanimatology
- No. 2
Selective blood purification using CytoSorb device in the treatment of liver failure (literary review and clinical cases)
Blood purification using CytoSorb device has become widespread in modern intensive care for septic shock and sepsis-associated acute kidney injury, as well as severe COVID-19 accompanied by severe hypercytokinemia. At the same time, effectiveness of CytoSorb in patients with severe hepatic failure is less clear in modern literature. Available data indicate high detoxification potential of CytoSorb in relation to the main «liver» factors of endogenous intoxication (bilirubin, bile acids, ammonia). Inclusion of CytoSorb cytokine adsorber in intensive therapy may be effective for acute liver failure due to correction of endogenous intoxication. This effect allows regression of clinical manifestations and probably contributes to compensation of liver dysfunction. The authors report successful blood purification in a patient with irreversible liver failure until orthotopic liver transplantation. This approach created conditions for relief of early transplant dysfunction. Considering simplicity and relatively low cost compared to other extracorporeal methods of liver function support, we can emphasize that CytoSorb cytokine adsorber appears to be perspective for intensive therapy in patients with severe liver failure.
- 19 April 2024
- Published by Media Sphere Publishing Group in Russian Journal of Anesthesiology and Reanimatology
- No. 2
Selective blood purification using CytoSorb device in the treatment of liver failure (literary review and clinical cases)
Blood purification using CytoSorb device has become widespread in modern intensive care for septic shock and sepsis-associated acute kidney injury, as well as severe COVID-19 accompanied by severe hypercytokinemia. At the same time, effectiveness of CytoSorb in patients with severe hepatic failure is less clear in modern literature. Available data indicate high detoxification potential of CytoSorb in relation to the main «liver» factors of endogenous intoxication (bilirubin, bile acids, ammonia). Inclusion of CytoSorb cytokine adsorber in intensive therapy may be effective for acute liver failure due to correction of endogenous intoxication. This effect allows regression of clinical manifestations and probably contributes to compensation of liver dysfunction. The authors report successful blood purification in a patient with irreversible liver failure until orthotopic liver transplantation. This approach created conditions for relief of early transplant dysfunction. Considering simplicity and relatively low cost compared to other extracorporeal methods of liver function support, we can emphasize that CytoSorb cytokine adsorber appears to be perspective for intensive therapy in patients with severe liver failure.
- Open Access
- 21 February 2024
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Messenger of ANESTHESIOLOGY AND RESUSCITATION
- Vol. 21 (1) , 46-52
The effect of renal replacement therapy on the concentration of tigecycline in the blood in patients with sepsis-associated acute kidney injury
The objective was to evaluate the effect of renal replacement therapy on the concentration of tigecycline in the blood in the treatment of patients with sepsis and acute kidney injury.Materials and methods. The serum level of tigecycline was analyzed in three patients with sepsis-associated acute kidney injury against the back -ground of renal replacement therapy (RRT) in the hemodiafiltration mode. The quantitative content of tigecycline was determined by high-performance liquid chromatography.Results. Significant variability of serum tigecycline levels was revealed in patients with sepsis-associated acute kidney injury (AKI) under the conditions of the use of RRT. The use of standard dosage regimens of tigecycline in this situation may be accompanied by both a significant increase in the concentration of the drug in the blood relative to the target values, and its low level, which does not reach the values of the minimum inhibitory concentration (MIC) for pathogenic strains.Conclusion. Significant variability of serum concentrations of tigecycline in patients with sepsis-associated AKI against the background of RRT causes the emergence of potential risks associated with both insufficient safety of treatment due to possible accumulation and significant excess of the target concentration value against the background of inhibition of the functions of the physiological excretory systems of the body, so with the low effectiveness of antibacterial therapy in conditions of increasing the rate of elimination of the drug from the systemic bloodstream due to extracorporeal clearance and reducing the concentration of the antibiotic to subtherapeutic.
- 21 February 2024
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Messenger of ANESTHESIOLOGY AND RESUSCITATION
- Vol. 21 (1) , 46-52
Open AccessThe effect of renal replacement therapy on the concentration of tigecycline in the blood in patients with sepsis-associated acute kidney injury
The objective was to evaluate the effect of renal replacement therapy on the concentration of tigecycline in the blood in the treatment of patients with sepsis and acute kidney injury.Materials and methods. The serum level of tigecycline was analyzed in three patients with sepsis-associated acute kidney injury against the back -ground of renal replacement therapy (RRT) in the hemodiafiltration mode. The quantitative content of tigecycline was determined by high-performance liquid chromatography.Results. Significant variability of serum tigecycline levels was revealed in patients with sepsis-associated acute kidney injury (AKI) under the conditions of the use of RRT. The use of standard dosage regimens of tigecycline in this situation may be accompanied by both a significant increase in the concentration of the drug in the blood relative to the target values, and its low level, which does not reach the values of the minimum inhibitory concentration (MIC) for pathogenic strains.Conclusion. Significant variability of serum concentrations of tigecycline in patients with sepsis-associated AKI against the background of RRT causes the emergence of potential risks associated with both insufficient safety of treatment due to possible accumulation and significant excess of the target concentration value against the background of inhibition of the functions of the physiological excretory systems of the body, so with the low effectiveness of antibacterial therapy in conditions of increasing the rate of elimination of the drug from the systemic bloodstream due to extracorporeal clearance and reducing the concentration of the antibiotic to subtherapeutic.
- Open Access
- 6 March 2023
- Published by Non-profit organization Nephrology in Nephrology (Saint-Petersburg)
- Vol. 27 (1) , 9-17
Paradigms of megapolis nephrology in a changing world: status, problems and prospects of development of the nephrological service of St. Petersburg
The course of the COVID-19 pandemic has led to a critical increase in the burden on virtually all major branches of the health care system in our country and abroad. The aim of this article is to analyse the activities of the different parts of the city nephrology service in Saint-Petersburg and to consider promising ways to improve it. The nephrology service for the adult population in St. Petersburg includes: outpatient service; inpatient service - 183 beds in 24-hour inpatient departments of the city; dialysis service - 10 dialysis units in municipal medical organizations, 5 in federal institutions, and 8 centers/departments operating in the framework of private-public partnership. The number of patients on dialysis programme decreased by 10.5 % to 1,839 in 2021. These changes are likely due to an increase in mortality among these patients in 2020 and 2021 which is a consequence not only of COVID-19 but also of the adverse impact of the pandemic on the health system. The proportion of patients treated as outpatients in private dialysis centres increased during the three-year period. The incidence of arteriovenous fistula formation in primary vascular access decreased from 33.2 % to 14.2 % in 2020 compared with 2019. At the same time, the use of temporary central venous catheters as primary vascular access for renal replacement therapy has increased significantly from 43.0 % to 61.9 %. The development of the nephrology service is largely determined by its funding. To compensate the costs of medical in stitutions in the city for conducting renal replacement therapy it is necessary to increase the tariffs of compulsory health insurance (CHI) by at least 50 %. In the medical organizations of Saint-Petersburg municipal and federal subordination the share of "artificial kidney" devices that have used up their resource is 32.2 %, and in a number of medical institutions it exceeds 50 %.
- 6 March 2023
- Published by Non-profit organization Nephrology in Nephrology (Saint-Petersburg)
- Vol. 27 (1) , 9-17
Open AccessParadigms of megapolis nephrology in a changing world: status, problems and prospects of development of the nephrological service of St. Petersburg
The course of the COVID-19 pandemic has led to a critical increase in the burden on virtually all major branches of the health care system in our country and abroad. The aim of this article is to analyse the activities of the different parts of the city nephrology service in Saint-Petersburg and to consider promising ways to improve it. The nephrology service for the adult population in St. Petersburg includes: outpatient service; inpatient service - 183 beds in 24-hour inpatient departments of the city; dialysis service - 10 dialysis units in municipal medical organizations, 5 in federal institutions, and 8 centers/departments operating in the framework of private-public partnership. The number of patients on dialysis programme decreased by 10.5 % to 1,839 in 2021. These changes are likely due to an increase in mortality among these patients in 2020 and 2021 which is a consequence not only of COVID-19 but also of the adverse impact of the pandemic on the health system. The proportion of patients treated as outpatients in private dialysis centres increased during the three-year period. The incidence of arteriovenous fistula formation in primary vascular access decreased from 33.2 % to 14.2 % in 2020 compared with 2019. At the same time, the use of temporary central venous catheters as primary vascular access for renal replacement therapy has increased significantly from 43.0 % to 61.9 %. The development of the nephrology service is largely determined by its funding. To compensate the costs of medical in stitutions in the city for conducting renal replacement therapy it is necessary to increase the tariffs of compulsory health insurance (CHI) by at least 50 %. In the medical organizations of Saint-Petersburg municipal and federal subordination the share of "artificial kidney" devices that have used up their resource is 32.2 %, and in a number of medical institutions it exceeds 50 %.
- Open Access
- 30 December 2022
- Published by Federal Scientific Center for Hygiene F.F.Erisman in Toxicological Review
- Vol. 30 (6) , 370-376
Prevalence, structure, frequency of complications and outcomes of treatment of rhabdomyolysis in acute exogenous intoxication in a multidisciplinary hospital
Introduction. The prevalence of rhabdomyolysis among people admitted to the hospital due to acute poisoning reaches, according to various foreign sources, from 30 to 40%. In 60% of cases, the development of rhabdomyolysis in adult patients is associated with acute exogenous intoxication. Currently, data on the prevalence, structure and outcomes of treatment of rhabdomyolysis in toxicological patients are mainly presented by the results of foreign clinical and epidemiological studies. The aim is to study the prevalence, structure, frequency of complications and outcomes of treatment of rhabdomyolysis in acute exogenous intoxication in a multidisciplinary hospital. Material and methods. The study included 1,363 patients who were treated from 2017 to 2020 with acute exogenous intoxication. During the study, 98 patients with rhabdomyolysis were selected from the general group. The frequency of poisoning with various toxicants was analyzed, the effects of which led to the development of rhabdomyolysis in acute exogenous intoxication. The incidence of acute kidney injury (AKI) was detected, the outcomes of acute poisoning treatment, the duration of inpatient treatment were determined, and a comparative analysis was carried out between groups of patients with rhabdomyolysis in acute exogenous intoxication (n=98) and without it (n=1265). Results. The prevalence of rhabdomyolysis among patients hospitalized for acute poisoning was 7%. The main reason for the development of rhabdomyolysis was the use of narcotic drugs - 87% of cases. The development of rhabdomyolysis in acute exogenous intoxication in 59.2% of cases is accompanied by the occurrence of AKI, which is significantly higher than among patients without rhabdomyolysis (11.6%). The occurrence of rhabdomyolysis in toxicological patients increases hospital mortality from 6.1 to 10.2%, as well as the duration of inpatient treatment and intensive care by 5.2 and 3.3 days, respectively. Limitations. The study was conducted based on only one multidisciplinary hospital in Moscow in the period from 2017 to 2020. Conclusion. Rhabdomyolysis is a serious complication of acute poisoning, the development of which significantly worsens the outcomes of treatment of patients with a toxicological profile, which requires the development of effective methods for the prevention, diagnosis and treatment of rhabdomyolysis in acute exogenous intoxication.
- 30 December 2022
- Published by Federal Scientific Center for Hygiene F.F.Erisman in Toxicological Review
- Vol. 30 (6) , 370-376
Open AccessPrevalence, structure, frequency of complications and outcomes of treatment of rhabdomyolysis in acute exogenous intoxication in a multidisciplinary hospital
Introduction. The prevalence of rhabdomyolysis among people admitted to the hospital due to acute poisoning reaches, according to various foreign sources, from 30 to 40%. In 60% of cases, the development of rhabdomyolysis in adult patients is associated with acute exogenous intoxication. Currently, data on the prevalence, structure and outcomes of treatment of rhabdomyolysis in toxicological patients are mainly presented by the results of foreign clinical and epidemiological studies. The aim is to study the prevalence, structure, frequency of complications and outcomes of treatment of rhabdomyolysis in acute exogenous intoxication in a multidisciplinary hospital. Material and methods. The study included 1,363 patients who were treated from 2017 to 2020 with acute exogenous intoxication. During the study, 98 patients with rhabdomyolysis were selected from the general group. The frequency of poisoning with various toxicants was analyzed, the effects of which led to the development of rhabdomyolysis in acute exogenous intoxication. The incidence of acute kidney injury (AKI) was detected, the outcomes of acute poisoning treatment, the duration of inpatient treatment were determined, and a comparative analysis was carried out between groups of patients with rhabdomyolysis in acute exogenous intoxication (n=98) and without it (n=1265). Results. The prevalence of rhabdomyolysis among patients hospitalized for acute poisoning was 7%. The main reason for the development of rhabdomyolysis was the use of narcotic drugs - 87% of cases. The development of rhabdomyolysis in acute exogenous intoxication in 59.2% of cases is accompanied by the occurrence of AKI, which is significantly higher than among patients without rhabdomyolysis (11.6%). The occurrence of rhabdomyolysis in toxicological patients increases hospital mortality from 6.1 to 10.2%, as well as the duration of inpatient treatment and intensive care by 5.2 and 3.3 days, respectively. Limitations. The study was conducted based on only one multidisciplinary hospital in Moscow in the period from 2017 to 2020. Conclusion. Rhabdomyolysis is a serious complication of acute poisoning, the development of which significantly worsens the outcomes of treatment of patients with a toxicological profile, which requires the development of effective methods for the prevention, diagnosis and treatment of rhabdomyolysis in acute exogenous intoxication.